Agata Rembielak is a Clinical Oncology Consultant at The Christie Hospital in Manchester and MAHSC Clinical Chair at The University of Manchester. Her research interests include non-melanoma skin cancer, particularly the role of radiotherapy and brachytherapy, and health-related quality of life. Within ESTRO she is a director at the course “Multidisciplinary management of non-melanoma skin cancer” and leads Skin Cancer and Soft Tissue Focus Group. She chairs the SIOG Task Force on non-melanoma skin cancer in older adults. She is a co-CI for the SCC-AFTER trial looking at the role of postoperative radiotherapy in high-risk skin SCC. Agata is also a proactive member of the BIR Oncolgoy & Radiotherapy SIG.
